Literature DB >> 6619801

Studies on heterotypic interference between influenza A and B viruses: a differential inhibition of the synthesis of viral proteins and RNAs.

N V Kaverin, N L Varich, E I Sklyanskaya, T V Amvrosieva, J Petrik, T C Vovk.   

Abstract

Mixed infection of MDCK cells with influenza A and influenza B viruses leads to a reduction in the rate of synthesis of haemagglutinin (HA) and nucleoprotein (NP) as compared to their rate of synthesis in cells separately infected with these viruses. The reduction is much stronger for influenza A virus proteins. The synthesis of the nonstructural NS1 protein of both viruses is relatively resistant to the heterotypic interference. The synthesis of virus-specific mRNAs exhibits the same pattern: the formation of the transcripts of HA and NP genes is much more drastically reduced than the synthesis of NS gene transcripts. The effect is strongly dependent on the multiplicity of infection and on the ratio of influenza A and B viruses in the inoculum. Primary transcription in the presence of cycloheximide is almost unchanged in doubly infected cells as compared to single infection, and no indication of differential inhibition has been observed. The results are discussed in connection with the mechanism of heterotypic interference and the regulation of influenza virus protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619801     DOI: 10.1099/0022-1317-64-10-2139

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.

Authors:  Taisuke Horimoto; Ayato Takada; Kiyoko Iwatsuki-Horimoto; Masato Hatta; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Limited compatibility of polymerase subunit interactions in influenza A and B viruses.

Authors:  Kerstin Wunderlich; Mindaugas Juozapaitis; Benjamin Mänz; Daniel Mayer; Veronika Götz; Andrea Zöhner; Thorsten Wolff; Martin Schwemmle; Arnold Martin
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

3.  The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA.

Authors:  M P Stevens; W S Barclay
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 4.  Viral interference-dominance of mutant viruses over wild-type virus in mixed infections.

Authors:  P Whitaker-Dowling; J S Youngner
Journal:  Microbiol Rev       Date:  1987-06

5.  A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.

Authors:  Rong Hai; Adolfo García-Sastre; David E Swayne; Peter Palese
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  Rescue of influenza B virus from eight plasmids.

Authors:  Erich Hoffmann; Kutubuddin Mahmood; Chin-Fen Yang; Robert G Webster; Harry B Greenberg; George Kemble
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

7.  Limited compatibility between the RNA polymerase components of influenza virus type A and B.

Authors:  Kiyoko Iwatsuki-Horimoto; Yasuko Hatta; Masato Hatta; Yukiko Muramoto; Hualan Chen; Yoshihiro Kawaoka; Taisuke Horimoto
Journal:  Virus Res       Date:  2008-05-02       Impact factor: 3.303

8.  Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin.

Authors:  Astrid Flandorfer; Adolfo García-Sastre; Christopher F Basler; Peter Palese
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 9.  Development and applications of single-cycle infectious influenza A virus (sciIAV).

Authors:  Aitor Nogales; Steven F Baker; William Domm; Luis Martínez-Sobrido
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

10.  Influenza A and B virus intertypic reassortment through compatible viral packaging signals.

Authors:  Steven F Baker; Aitor Nogales; Courtney Finch; Kevin M Tuffy; William Domm; Daniel R Perez; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.